Results 61 to 70 of about 2,525 (118)

One haemolytic anaemia may hide another: Paroxysmal nocturnal haemoglobinuria masquerading as Plasmodium falciparum infection

European Journal of Case Reports in Internal Medicine
Background: Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, genetic and acquired haematologic disease that causes complement-mediated intravascular haemolytic anaemia, thrombosis and bone marrow failure.
Alexandre-Raphael Wery, Coline Mortier, Quentin Cabrera, Mohamadou Niang, Moumini Kone, Sarah Permal   +5 more
doaj   +1 more source

The future of complement therapeutics

Exploration of Immunology
Complement is both evolutionary and scientifically old. It predates the adaptive immunity by some 600 million years and was first described in 1905 by Jules Bordet and Paul Ehrlich. For the most of its, the existence complement system has been ignored by
Martin Kolev, Kollu Nageswara Rao, Michael Yeh, Pascal Deschatelets   +3 more
doaj   +1 more source

DETECTION AND FOLLOW UP OF PNH CLONE BY MEASURING CD55 AND CD59 EXPRESSION ON NEUTROPHILS

Zdravniški Vestnik, 2004
Background. Paroxysmal nocturnal haemoglobinuria (PNH) is an acquired clonal haematopoietic stem cell disorder characterised by intravascular haemolysis, bone marrow failure and increased tendency to thrombosis.
Uroš Mlakar, Darja Žontar
doaj  

Hemoglobinuria paroxística nocturna: Actualización Paroxysmal nocturnal haemoglobinuria

Revista Cubana de Hematología, Inmunología y Hemoterapia, 2003
La hemoglobinuria paroxística nocturna (HPN) es una enfermedad clonal y adquirida causada por una mutación somática en el gen PIG-A que se encuentra en el cromosoma X y codifica una proteina involucrada en la síntesis del glicosilfosfatidilinositol (GPI),
María Teresa Milanés Roldán, Norma Fernández Delgado, Teresa Fundora Sarraff, Juan Carlos Jaime Facundo, Porfirio Hernández Ramírez   +4 more
doaj  

Is Allogeneic Stem Cell Transplantation a Good Option for Paroxysmal Nocturnal Haemoglobinuria?

European Medical Journal Hematology, 2020
Fatma Keklik Karadağ, Güray Saydam, Fahri Sahin   +2 more
doaj   +1 more source

Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies. [PDF]

Eur J Haematol
Röth A, Fu R, He G, Alzahrani H, Chou SC, Hicheri Y, Kaźmierczak M, Recova VL, Uchiyama M, Vladareanu AM, Beveridge L, Buatois S, Buri M, Compagno N, Shi D, Balachandran N, Sreckovic S, Scheinberg P.   +17 more
europepmc   +1 more source

Editorial: Biological aspects of bone marrow failure

Frontiers in Oncology, 2023
Panagiotis Diamantopoulos, Serine Avagyan, Elena Solomou   +2 more
doaj   +1 more source

Aplastic anaemia with small paroxysmal nocturnal haemoglobinuria clones developing during osimertinib therapy for non-small cell lung cancer. [PDF]

Leuk Res Rep
Morimoto H, Katagiri S, Omori T, Otsuki S, Yoshizawa S, Furuya N, Fujimoto H, Takeuchi H, Gotoh A, Akahane D.   +9 more
europepmc   +1 more source

A case report of CD4^- CD8⁺ CD56^- TCRγδ⁺ T-large granular lymphocytic leukaemia with severe aplastic anemia and a PNH clone. [PDF]

Ann Hematol
Du Y, Zhang J, Jin S.
europepmc   +1 more source

FACIT-fatigue score and treatment quality assessment for paroxysmal nocturnal hemoglobinuria patients treated with Eculizumab in Türkiye. [PDF]

PLoS One
Narlı Özdemir Z, Keklik Karadağ F, Acar NG, Aydoğan M, Yavaşoğlu F, Temiz F, Güneş A, Akyol G, Erol HA, Mehtap Ö, Okan V, Kakçı M, Kendir İC, Köksal T, Iltar U, Esen R, Korkmaz G, Ayer M, Oğuz E, Salim O, Tombak A, Özet G, Sönmez M, Güler N, Yilmaz M, Özcan MA, Ünal A, Tuğlular T, Toprak SK, Güvenç B, Yenerel MN, İlhan O, Saydam G, Şahin F.   +33 more
europepmc   +1 more source